Venus Remedies Hits 52-Week Low of Rs 1,630: What's Dragging the Stock Today

Published: 24 September 2026 at 9:19 AM IST

Venus Remedies Share Price opened the session at Rs 1,630 and last traded at Rs 1,646, down 0.01% from the previous close of Rs 1,646.1. The stock marked a fresh 52-week low of Rs 1,630 and carried a market capitalisation of Rs 2,150.28 crore. Venus Remedies Ltd. (VENUSREM) is therefore in the spotlight today because the price event is verified by the day’s range and the one-year low level, while the broader data set gives investors a clear view of valuation, earnings and sector standing. Univest tracks this move as a fresh market event, not as a judgment on future direction. The data confirms what happened today; it does not establish a company-specific cause.

For readers following Venus Remedies Share Price Today, the session was narrow but important because the stock touched its yearly low of Rs 1,630 before recovering to Rs 1,646. That makes Venus Remedies Stock News relevant for searchers looking for Venus Remedies Share Price, Venus Remedies Share Price News and Venus Remedies Share Price Update. The available figures also place the move against a market cap of Rs 2,150.28 crore, a P/E of 18.94, P/B of 3.2, ROE of 16.79, ROCE of 21.88, EPS of 86.91, book value of Rs 513.74 and dividend yield of 0.61%.

Venus Remedies Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,646
Previous Close	Rs 1,646.1
Today's Move	Rs -0.1 (-0.01%)
Open	Rs 1,630
High	Rs 1,649.85
Low	Rs 1,630
Turnover	Rs 0.01 crore
Market Capitalisation	Rs 2,150.28 crore

Venus Remedies Ltd. (VENUSREM) traded at Rs 1,646. versus the previous close of Rs 1,646.1, a fall of 0.01%. The stock opened at Rs 1,630, reached Rs 1,649.85, touched Rs 1,630.

Venus Remedies Share Price traded between Rs 1,630 and Rs 1,649.85 during the session and ended at Rs 1,646, just Rs 0.10 below the previous close of Rs 1,646.1. The day’s change of -0.01% shows an almost unchanged finish, even though the stock briefly touched its fresh 52-week low of Rs 1,630. The opening level was also Rs 1,630, matching the low for the day, which keeps the price action tightly contained around the lower end of the session range. Turnover stood at Rs 0.01 crore, and the market capitalisation remained Rs 2,150.28 crore. A fresh 52-week low event is the main market fact to track here, because it places Venus Remedies Share Price in a distinct yearly-low search category for Venus Remedies Stock News and Venus Remedies Share Price Today.

In practical terms, the session shows a stock that moved within a narrow band after opening at its yearly low. The close above the day’s low indicates some recovery from that point, but the stock still finished very close to the lower end of the range. For those tracking Venus Remedies Share Price Live, the key observations are the low of Rs 1,630, the close of Rs 1,646, and the market cap of Rs 2,150.28 crore. The price event is factual and measurable; the supplied data does not establish a company-specific catalyst. From here, the broader question for Venus Remedies Share Price is how valuation and fundamentals compare with listed peers and the wider pharmaceutical universe.

Venus Remedies Ltd. (VENUSREM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,150.28 crore
P/E Ratio	18.94x
P/B Ratio	3.2x
ROE	16.79%
ROCE	21.88%
EPS	Rs 86.91
Book Value Per Share	Rs 513.74
Dividend Yield	0.61%

Venus Remedies Ltd. (VENUSREM) fundamental metrics show P/E 18.94x, P/B 3.2x, ROE 16.79%, ROCE 21.88%. These figures provide context only and are not a buy or sell signal.

Venus Remedies Ltd. has a market capitalisation of Rs 2150.28 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.94x, P/B at 3.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.79% and ROCE of 21.88%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 86.91, book value per share of Rs 513.74, dividend yield of 0.61%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.33x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	18.94x
Benchmark Median P/E	32.33x
Benchmark Average P/E	50.2x
Benchmark P/E Range	3.48x to 762.66x
Company P/B Ratio	3.2x
Benchmark Median P/B	2.95x
Company ROE	16.79%
Benchmark Median ROE	11.69%
Company ROCE	21.88%
Benchmark Median ROCE	13.32%
Company Market Capitalisation	Rs 2,150.28 crore
Benchmark Median Market Cap	Rs 745.38 crore

Venus Remedies Ltd. (VENUSREM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Venus Remedies Ltd. (VENUSREM) has a P/E ratio of 18.94x, which is below the benchmark median of 32.33x, a difference of -41.42%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Venus Remedies Ltd. (VENUSREM) has a ROE of 16.79%, which is above the benchmark median of 11.69%, a difference of +43.63%. Venus Remedies Ltd. (VENUSREM) has a ROCE of 21.88%, which is above the benchmark median of 13.32%, a difference of +64.26%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sai Parenteral's Ltd.	SAIPARENT	2,237.24	135.74	2.87	4.88	6.1
Windlas Biotech Ltd.	WINDLAS	2,274.83	33.46	4.32	12.52	16.06
Fredun Pharmaceuticals Ltd.	FREDUN	2,324.64	53.81	7.99	16.09	21.34
Beta Drugs Ltd.	BETA	2,341.02	58.65	9.28	23.95	25.23
Indoco Remedies Ltd.	INDOCO	2,347.74	412.58	2.33	-10.13	0.79

Venus Remedies Ltd. (VENUSREM) has a P/E ratio of 18.94x compared with the displayed peer median of 58.65x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.79% compares with a peer median of 12.52% across the companies shown in the table. ROCE stood at 21.88% versus the displayed peer median of 16.06%, providing a capital-efficiency comparison. Venus Remedies Ltd. (VENUSREM) has a market capitalisation of Rs 2,150.28 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Venus Remedies

• Venus Remedies Share Price hit a fresh 52-week low of Rs 1,630 and ended at Rs 1,646.
• The session change was -0.01% versus the previous close of Rs 1,646.1.
• Market capitalisation stood at Rs 2,150.28 crore during the latest update.
• P/E of 18.94 is below the industry median of 32.33 in the same industry benchmark.
• ROE of 16.79 and ROCE of 21.88 are both above the industry median values in the supplied sector snapshot.

About Venus Remedies

Venus Remedies Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data places Venus Remedies Share Price inside a listed pharma universe that includes both higher and lower valuation multiples across the same-industry benchmark. The latest financial indicators show EPS of 86.91, book value of Rs 513.74 and dividend yield of 0.61%. The company’s recent quarterly numbers include revenue of Rs 1,788.6 crore in Jun 2026 and net profit of Rs 229.7 crore in the same quarter. These are the core facts available for Venus Remedies Company News and Venus Remedies Share Price Live coverage.

Track Venus Remedies Share Price on Univest

Use Venus Remedies Ltd. (VENUSREM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Univest allows readers to track Venus Remedies Share Price, Venus Remedies Share Price Today, Venus Remedies Stock News and Venus Remedies Share Price Update in one place. Users can follow live price, key valuation ratios, shareholding pattern, 52-week levels and company insights through the stock page. For Venus Remedies Share Price research, Univest presents the event, the metrics and the sector context together.

Frequently Asked Questions

Why did Venus Remedies Share Price hit a fresh 52-week low?

Ans. The stock touched Rs 1,630, its fresh 52-week low, and ended at Rs 1,646. The supplied data confirms the price event but does not establish a company-specific cause for the move.

What is Venus Remedies Share Price today?

Ans. Venus Remedies Share Price today was Rs 1,646, compared with the previous close of Rs 1,646.1. The stock finished almost unchanged, even after testing Rs 1,630 during the session. The stock moved -0.01% during the session.

What is Venus Remedies Share Price News today?

Ans. Venus Remedies Share Price News today centres on the fresh 52-week low event. The session range, close and market capitalisation of Rs 2,150.28 crore are the main verified facts in view.

How is Venus Remedies valued in the market?

Ans. Venus Remedies has a P/E of 18.94 and a P/B of 3.2. In the same-industry benchmark, its P/E is below the median of 32.33 and its P/B is slightly above the median of 2.95.

What do Venus Remedies ROE and ROCE show?

Ans. Venus Remedies reports ROE of 16.79 and ROCE of 21.88. Both measures are above the same-industry median values in the supplied benchmark, which helps frame the company’s return profile. ROE stands at 16.79%.

How does Venus Remedies compare with peers?

Ans. Venus Remedies’ market cap of Rs 2,150.28 crore is close to several listed peers. Its P/E is lower than the supplied peer figures for Sai Parenteral, Windlas Biotech, Fredun Pharmaceuticals, Beta Drugs and Indoco Remedies.

What are the key Venus Remedies fundamentals?

Ans. Key fundamentals include EPS of 86.91, book value of Rs 513.74, dividend yield of 0.61%, ROE of 16.79 and ROCE of 21.88. These figures help define the current Venus Remedies Share Price context.

What is the market capitalisation of Venus Remedies?

Ans. Venus Remedies has a market capitalisation of Rs 2,150.28 crore. That places Venus Remedies Share Price above the same-industry median market cap of Rs 745.38 crore in the supplied benchmark.

Where can I track Venus Remedies Share Price?

Ans. Readers can track Venus Remedies Share Price on Univest, where live price, valuation ratios, 52-week levels, shareholding pattern and company insights are presented together for quick reference. The stock moved -0.01% during the session.